Shusuke Yasuda

517 total citations
23 papers, 418 citations indexed

About

Shusuke Yasuda is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Shusuke Yasuda has authored 23 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Shusuke Yasuda's work include Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (4 papers) and Cancer Mechanisms and Therapy (3 papers). Shusuke Yasuda is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (4 papers) and Cancer Mechanisms and Therapy (3 papers). Shusuke Yasuda collaborates with scholars based in Japan, United States and Netherlands. Shusuke Yasuda's co-authors include Toshiyuki Sakai, Mano Horinaka, Shingo Yogosawa, Yoshitaka Nakamura, Yasumasa Yamada, Qi Sun, Yoshihiro Sowa, Tatsushi Yoshida, Yosuke Iizumi and Makoto Wada and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Shusuke Yasuda

23 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shusuke Yasuda Japan 13 265 72 62 48 40 23 418
Bendangla Changkija India 9 233 0.9× 138 1.9× 46 0.7× 51 1.1× 18 0.5× 14 511
Sima Mansoori Derakhshan Iran 5 325 1.2× 69 1.0× 19 0.3× 46 1.0× 32 0.8× 22 533
Gülseren Bağcı Türkiye 11 206 0.8× 45 0.6× 50 0.8× 43 0.9× 13 0.3× 36 411
Weili Min China 17 299 1.1× 132 1.8× 34 0.5× 42 0.9× 19 0.5× 26 591
Shreya Kar Singapore 6 290 1.1× 138 1.9× 19 0.3× 37 0.8× 29 0.7× 8 500
Ali H. El‐Bahrawy Egypt 10 179 0.7× 122 1.7× 49 0.8× 37 0.8× 9 0.2× 18 466
Shankar Jagadeesh United States 12 353 1.3× 56 0.8× 35 0.6× 63 1.3× 14 0.3× 18 537
Angela Cisneros United States 8 237 0.9× 57 0.8× 50 0.8× 14 0.3× 17 0.4× 13 395
Jianlin Ren China 9 326 1.2× 127 1.8× 26 0.4× 20 0.4× 17 0.4× 18 578

Countries citing papers authored by Shusuke Yasuda

Since Specialization
Citations

This map shows the geographic impact of Shusuke Yasuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shusuke Yasuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shusuke Yasuda more than expected).

Fields of papers citing papers by Shusuke Yasuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shusuke Yasuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shusuke Yasuda. The network helps show where Shusuke Yasuda may publish in the future.

Co-authorship network of co-authors of Shusuke Yasuda

This figure shows the co-authorship network connecting the top 25 collaborators of Shusuke Yasuda. A scholar is included among the top collaborators of Shusuke Yasuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shusuke Yasuda. Shusuke Yasuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Masuda, Mitsuharu, Mano Horinaka, Shusuke Yasuda, et al.. (2023). Discovery of cancer-preventive juices reactivating RB functions. Environmental Health and Preventive Medicine. 28(0). 54–54. 3 indexed citations
3.
Horinaka, Mano, Yosuke Iizumi, Hideki Takakura, et al.. (2022). Salicylic acid directly binds to ribosomal protein S3 and suppresses CDK4 expression in colorectal cancer cells. Biochemical and Biophysical Research Communications. 628. 110–115. 8 indexed citations
4.
Horinaka, Mano, et al.. (2021). Novel RAF/MEK inhibitor CH5126766/VS‐6766 has efficacy in combination with eribulin for the treatment of triple‐negative breast cancer. Cancer Science. 112(10). 4166–4175. 6 indexed citations
5.
Yasuda, Shusuke, et al.. (2021). Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells. Biochemical and Biophysical Research Communications. 590. 55–62. 22 indexed citations
6.
Horinaka, Mano, et al.. (2020). The HDAC inhibitor OBP-801 suppresses the growth of myxofibrosarcoma cells.. PubMed. 25(1). 464–471. 5 indexed citations
7.
Yasuda, Shusuke, Mano Horinaka, & Toshiyuki Sakai. (2019). Sulforaphane enhances apoptosis induced by Lactobacillus pentosus strain S‑PT84 via the TNFα pathway in human colon cancer cells. Oncology Letters. 18(4). 4253–4261. 13 indexed citations
8.
Ota, Yosuke, Yukihiro Itoh, Shusuke Yasuda, et al.. (2018). Design, synthesis and evaluation of γ-turn mimetics as LSD1-selective inhibitors. Bioorganic & Medicinal Chemistry. 26(3). 775–785. 15 indexed citations
9.
Horinaka, Mano, et al.. (2018). Sulindac sulfone inhibits the mTORC1 pathway in colon cancer cells by directly targeting voltage-dependent anion channel 1 and 2. Biochemical and Biophysical Research Communications. 505(4). 1203–1210. 13 indexed citations
10.
Horinaka, Mano, Shusuke Yasuda, Yoshihiro Sowa, et al.. (2017). FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells. Oncology Reports. 39(2). 627–632. 13 indexed citations
11.
Horinaka, Mano, et al.. (2017). Sulforaphane suppresses cell growth and collagen expression of keloid fibroblasts. Wound Repair and Regeneration. 25(2). 224–233. 17 indexed citations
12.
13.
Wada, Makoto, Mano Horinaka, Shusuke Yasuda, et al.. (2015). PDK1 is a potential therapeutic target against angiosarcoma cells. Journal of Dermatological Science. 78(1). 44–50. 27 indexed citations
14.
Horinaka, Mano, et al.. (2014). Myeloid zinc finger 1 mediates sulindac sulfide-induced upregulation of death receptor 5 of human colon cancer cells. Scientific Reports. 4(1). 15 indexed citations
15.
Taniguchi, Hiroya, Mano Horinaka, Tatsushi Yoshida, et al.. (2012). Targeting the Glyoxalase Pathway Enhances TRAIL Efficacy in Cancer Cells by Downregulating the Expression of Antiapoptotic Molecules. Molecular Cancer Therapeutics. 11(10). 2294–2300. 32 indexed citations
16.
Sowa, Yoshihiro, Shusuke Yasuda, Ryoichi Tanaka, et al.. (2012). Retinoblastoma gene‐independent G1 phase arrest by flavone, phosphatidylinositol 3‐kinase inhibitor, and histone deacetylase inhibitor. Cancer Science. 103(12). 2139–2143. 10 indexed citations
17.
18.
Yasuda, Shusuke, et al.. (2009). Cucurbitacin B induces G2 arrest and apoptosis via a reactive oxygen species‐dependent mechanism in human colon adenocarcinoma SW480 cells. Molecular Nutrition & Food Research. 54(4). 559–565. 79 indexed citations
19.
Hitomi, Toshiaki, Y. Matsuzaki, Shusuke Yasuda, et al.. (2007). Oct‐1 is involved in the transcriptional repression of the p15INK4b gene. FEBS Letters. 581(6). 1087–1092. 20 indexed citations
20.
Xuan, Yanyan, et al.. (1994). [Growth inhibition of the emulsion from to Brucea javanica cultured human carcinoma cells].. PubMed. 21(14). 2421–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bendangla Changkija Breakdown of academic impact, for papers by Sima Mansoori Derakhshan Breakdown of academic impact, for papers by Gülseren Bağcı Breakdown of academic impact, for papers by Weili Min Breakdown of academic impact, for papers by Shreya Kar Breakdown of academic impact, for papers by Ali H. El‐Bahrawy Breakdown of academic impact, for papers by Shankar Jagadeesh Breakdown of academic impact, for papers by Angela Cisneros Breakdown of academic impact, for papers by Jianlin Ren
Rankless by CCL
2026